Novartis: Asthma trials

The registry lists 105 Asthma studies with Novartis as lead sponsor. 3 are open to participants now and 61 have results posted.

Phase 1 8Phase 2 49Phase 3 33Phase 4 13No phase 8(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent AsthmaCompletedNCT00403637Phase 2/3
• Study of Omalizumab in Moderate to Severe Bronchial AsthmaCompletedNCT00232050Phase 3
• Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.CompletedNCT00219323Phase 3
• A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With AsthmaCompletedNCT00130351Phase 3
• Efficacy and Safety of Omalizumab in Patients With Severe Persistent AsthmaCompletedNCT00046748Phase 3